“Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals”. Journal of Pharmaceutical Negative Results, Nov. 2022, pp. 921-9, https://doi.org/10.47750/pnr.2022.13.S09.110.